Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Pregnancy and Medication Impact, and HIV Research and Treatment.
Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir
Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy
Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list
Improving Respiratory Support Practices to Reduce Chronic Lung Disease in Premature Infants
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV
Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV
Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission
Congenital Cytomegalovirus and HIV Perinatal Transmission
Praziquantel for the treatment of schistosomiasis during human pregnancy
Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Pharmacokinetics of tenofovir during pregnancy and postpartum
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Raltegravir Pharmacokinetics During Pregnancy
Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing
Can traditional birth attendants be trained to accurately identify septic infants, initiate antibiotics, and refer in a rural African setting?
Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection